Journal article
Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study
Abstract
BACKGROUND: The optimal duration of oral anticoagulant therapy after a first, unprovoked venous thromboembolism is controversial due to tightly balanced risks and benefits of indefinite anticoagulation. Risk stratification tools may assist in decision making.
OBJECTIVES: We sought to determine the relationship between residual pulmonary embolism assessed by baseline ventilation-perfusion scan after completion of 5-7months of oral anticoagulant …
Authors
Wan T; Rodger M; Zeng W; Robin P; Righini M; Kovacs MJ; Tan M; Carrier M; Kahn SR; Wells PS
Journal
Thrombosis Research, Vol. 162, , pp. 104–109
Publisher
Elsevier
Publication Date
2 2018
DOI
10.1016/j.thromres.2017.11.020
ISSN
0049-3848